Envíos recientes

Mostrando ítems 961-965 de 11841

A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

2023- Santos, J.R.; Domingo, P.; Portilla, J.; Gutiérrez, F.; Imaz, A.; [et al.]
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis

2023- Coto-Segura, P.; Segú-Vergés, C.; Martorell, A.; Moreno-Ramírez, D.; Jorba, G.; [et al.]
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative

2023- Leon Rapoport, B.; Garcia-Morillo, M.; Font, C.; Samoon, Z.; Jabbar, A.A.; [et al.]
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

2023- Mosquera Orgueira, Adrián; Díaz Arias, José; Serrano Martín, R.; Portela Piñeiro, V.; Cid López, Miguel; [et al.]
A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes

2023- Coral, D.E.; Fernández Tajes, Juan; Tsereteli, N.; Pomares-Millan, H.; Fitipaldi, H.; [et al.]